Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?

Townend, Jon (Principal Investigator)
Ferro, Charles (Co-Investigator)
Steeds, Richard (Co-Investigator)
Stewart, Paul (Co-Investigator)

Short title	Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Status	Finished
Effective start/end date	1/03/05 → 28/02/07

Funding

British Heart Foundation

1 Review article

Chronic kidney disease-associated cardiomyopathy: clinical features, pathophysiology and treatment
Edwards, N. C., Pavlovic, D., Ferro, C. J. & Townend, J. N., 2 Jan 2026, (E-pub ahead of print) In: Nature Reviews Cardiology. 15 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
425 Downloads (Pure)